Prescription Drug Overdose/Misuse

Prevention


 

The Governor’s Task Force to Address Substance Use Disorders

Public Comments – August 2018

August 15, 2018 Meeting
Presented by Task Force Chair, Kansas Dept. of Health and Environment Chief Medical Officer, Dr. Greg Lakin
Wednesday, August 15, 2018
1 – 4pm
Kansas Health Institute
Bluestem Conf. Room
212 SW 8th Avenue
Topeka, KS 66604
For more information or to RSVP, contact LWhite@khi.org
To learn more about Governor Jeff Colyer, M.D.’s Executive Order to Address Substance Use Disorders, visit:
https://governor.kansas.gov/governor-jeff-colyer-m-d-signs-executive-order-18-09-creating-governors-task-force-to-address-substance-use-disorders/.

August 23, 2018 Meeting
Presented by Task Force Chair, Kansas Dept. of Health and Environment Chief Medical Officer, Dr. Greg Lakin
Thursday, August 15, 2018
9am – 12 noon
Kansas Health Institute
Bluestem Conf. Room
212 SW 8th Avenue
Topeka, KS 66604
For more information or to RSVP, contact LWhite@khi.org
To learn more about Governor Jeff Colyer, M.D.’s Executive Order to Address Substance Use Disorders, visit:
https://governor.kansas.gov/governor-jeff-colyer-m-d-signs-executive-order-18-09-creating-governors-task-force-to-address-substance-use-disorders/.

June 28, 2018 – SUD Task Force Meeting Minutes |
June 28, 2018 - SUD Task Force Meeting Outcomes: Characterization of Recommendations

May 24, 2018 - SUD Task Force Meeting Minutes |
May 24, 2018 - SUD Task Force Meeting Outcomes: Characterization of Recommendations

The Governor’s Task Force to Address Substance Use Disorders is interested to receive written public comment to inform their selection of recommendations.
Please submit written comments to Carlie Houchen.
Comments may be submitted one of two ways:

  1. Via email to chouchen@khi.org; OR
  2. Via mail or delivery to the Kansas Health Institute, Attn: Carlie Houchen, 212 SW 8th Ave, Topeka, KS 66211.

Materials must be received by close of business on Thursday, August 9. Subsequently, submitted materials will be shared with Task Force members electronically ahead of their meeting on Wednesday, August 15.

In written comments please indicate which of the following topics the testimony pertains to:

  • Provider Education
  • Prevention
  • Treatment & Recovery
  • Law Enforcement
  • Neonatal Abstinence Syndrome (NAS)
  • Other

This information will be used to sort the testimony for the ease of Task Force member review. If you have questions, please contact Carlie Houchen at chouchen@khi.org or 785.233.5443.

 


prescription opioids cam be addictive and damgerous


Kansas Special Emphasis Reports

 

Drug Poisoning Morbidity in Kansas
Drug Poisoning Morbidity in Kansas

 
Prescription Opioid Kansas Map
Prescription Opioid Kansas Chart

 
Prescription Opioid Kansas Chart
Prescription Opioid Kansas Map